NeoGenomics Inc. Logo

NeoGenomics Inc. (NEO)

BMV

Currency in MXN
176.40
0.00 (0.00%)

Closed

Aug 21, 2026

Day's Range

176.40
176.40

52 wk Range

176.40
217.50

Overview - NEO - NeoGenomics Inc.

Key Statistics

Valuation

Enterprise Value

388.60B

P/E (Trailing)

‪-209.99‬

PEG Ratio

‪1.98‬

Price / Sales (TTM)

‪29.57‬

Price / Book

‪1.65‬

EV / EBITDA

‪944.12‬

Profitability

Gross Margin

‪45.56%‬

Profit Margin

‪-6.77%‬

Operating Margin

‪-4.84%‬

Return on Assets

‪-1.88%‬

Return on Equity

‪-6.32%‬

Ownership

Shares Outstanding

127.91M

Float

117.03M

Held by Insiders

‪2.06%‬

Held by Institutions

‪115.55%‬

Price stats

Beta

‪1.73‬

50-Day Avg

‪176.40‬

200-Day Avg

‪203.04‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 16, 2025

Screened by Zoya using the AAOIFI methodology.

Peers - NEO - NeoGenomics Inc.

Peer Comparison

Compared with companies in Diagnostics & Research listed on BMV.

Profile Summary - NEO - NeoGenomics Inc.

About

NeoGenomics Inc. is a leading cancer diagnostics company specializing in oncology genetics testing and information services. It offers one of the most comprehensive menus of oncology-focused tests worldwide, including next-generation sequencing (NGS), comprehensive genomic profiling, and advanced assays like RaDaR ST…

SectorHealthcare
IndustryDiagnostics & Research
Employees2.20K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.